Burrard Pharmaceuticals, established in 2005, is an international leader in the biotechnology, manufacturing, and pharmaceutical industries, headquartered in Canada. The company prides itself on its state-of-the-art facilities and operational efficiency, which allow for diverse production capabilities while adhering to pharmaceutical GMP standards.
Burrard Pharmaceuticals boasts a comprehensive portfolio focusing extensively on oncology and injectable products. Their expert integration of technology and unique processes ensures they remain at the cutting edge of drug manufacturing and technology transfer. With a commitment to delivering customized pharmacological solutions, they position themselves as a trusted partner in drug discovery and manufacturing, maximizing return on investment.
While there are no recent investments reported, the company's established reputation and comprehensive expertise make it a strong candidate for investors seeking to enter the pharmaceutical sector.